Abstract
• Patients with homozygous familial hypercholesterolemia (HoFH) have increased cardiovascular risk. • Coronavirus disease 2019 (COVID-19) pandemic affected healthy life behaviors and anxiety of patients with HoFH. • Fear of COVID-19 leads to avoidance of seeking medical care. • As a hospital-based treatment, lipid apheresis is disrupted during the pandemic.